Skip to main content
NewslettersWatchlist

Ambrx Biopharma Inc ADR(AMAM-Q)
NASDAQ

Today's Change
Delayed Last Update

Ambrx Biopharma Inc. to Participate in Upcoming Investor Conferences

Business Wire - Fri May 27, 2022

Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced that Feng Tian, Ph.D., Chairman of the Board, President and CEO of Ambrx, will participate in two upcoming investor conferences in June.

Cowen’s 3rd Annual Oncology Innovation Summit. Dr. Tian will participate in an analyst led fireside chat on Thursday, June 2 at 11:30 AM Pacific Time / 2:30 PM Eastern Time.

JMP Securities Life Sciences Conference. Dr. Tian will present on Thursday, June 16 at 11:00 AM Pacific Time / 2:00 PM Eastern Time.

Interested parties can access the live and pre-recorded webcasts for these conferences from the Investor Relations section of the company's website at www.Ambrx.com. The webcast replays will be available after the conclusion of the respective presentations for approximately 90 days.

About Ambrx Biopharma Inc. (Ambrx)

Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. These include next generation antibody drug conjugates (ADCs), bispecifics, targeted immuno-oncology therapies, novel cytokines to modulate the immune system, and long-acting therapeutic peptides for metabolic and cardiovascular disease. Ambrx is advancing a robust portfolio of clinical and preclinical programs designed to optimize efficacy, safety and ease of use, in multiple therapeutic areas, including its lead product candidate ARX788. In addition, Ambrx has clinical collaborations with multiple partners, for drug candidates generated using Ambrx technology. For more information, please visit www.ambrx.com.

Provided Content: Content provided by Business Wire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

market news
At midday: TSX slips as material stocks weigh
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 16.
inside the market
What every Canadian investor needs to know today
Traders work on the floor of the New York Stock Exchange during morning trading on May 17, 2024 in New York City. Wall Street stocks opened little changed May 17 after pulling back from a record run where the Dow exceeded 40,000 points for the first time. Around 10 minutes into trading the Dow Jones Industrial Average was steady at 39,872.66. (Photo by ANGELA WEISS / AFP) (Photo by ANGELA WEISS/AFP via Getty Images)
opinion
This Canadian aerospace stock deserves a place on your watch list
Robert Tattersall
market news
The close: TSX pulls back as resource shares slide; Nvidia rallies in post market on earnings beat
Traders work on the floor of the New York Stock Exchange during morning trading on May 17.
inside the market
What every Canadian investor needs to know today
A screen tracks NVIDIA Corp. as a trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 23, 2023. REUTERS/Brendan McDermid/File Photo
globe investor
Earnings from AI-heavyweight Nvidia to test U.S. stocks’ record run
A sign is posted in front of Nvidia headquarters on May 21 in Santa Clara, California.
market news
The close: S&P 500 and TSX squeak out record highs after Fed comments
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.
report on business
ReconAfrica agrees to pay out more than $10-million over allegedly misleading disclosure
ReconAfrica oil drilling site in Namibia for Geoffrey York and Emma Graney story.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).